Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 466 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is M  [Clear All Filters]
2010
Liu J, Deng Y, Li Q, Dey AK, Moore JP, Lu M.  2010.  Role of a putative gp41 dimerization domain in human immunodeficiency virus type 1 membrane fusion.. J Virol. 84(1):201-9.
Kang X, Kim H-J, Ramirez M, Salameh S, Ma X.  2010.  The septic shock-associated IL-10 -1082 A > G polymorphism mediates allele-specific transcription via poly(ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells.. J Immunol. 184(7):3718-24.
Bontjer I, Melchers M, Eggink D, David K, Moore JP, Berkhout B, Sanders RW.  2010.  Stabilized HIV-1 envelope glycoprotein trimers lacking the V1V2 domain, obtained by virus evolution.. J Biol Chem. 285(47):36456-70.
Bontjer I, Melchers M, Eggink D, David K, Moore JP, Berkhout B, Sanders RW.  2010.  Stabilized HIV-1 envelope glycoprotein trimers lacking the V1V2 domain, obtained by virus evolution.. J Biol Chem. 285(47):36456-70.
Zhang Y, Ma X.  2010.  Triptolide inhibits IL-12/IL-23 expression in APCs via CCAAT/enhancer-binding protein alpha.. J Immunol. 184(7):3866-77.
2009
Ingallinella P, Bianchi E, Ladwa NA, Wang Y-J, Hrin R, Veneziano M, Bonelli F, Ketas TJ, Moore JP, Miller MD et al..  2009.  Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency.. Proc Natl Acad Sci U S A. 106(14):5801-6.
Ingallinella P, Bianchi E, Ladwa NA, Wang Y-J, Hrin R, Veneziano M, Bonelli F, Ketas TJ, Moore JP, Miller MD et al..  2009.  Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency.. Proc Natl Acad Sci U S A. 106(14):5801-6.
Nociari M, Ocheretina O, Murphy M, Falck-Pedersen E.  2009.  Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling.. J Virol. 83(9):4081-91.
Dey AK, David KB, Lu M, Moore JP.  2009.  Biochemical and biophysical comparison of cleaved and uncleaved soluble, trimeric HIV-1 envelope glycoproteins.. Virology. 385(1):275-81.
Mazloum N, Holloman WK.  2009.  Brh2 promotes a template-switching reaction enabling recombinational bypass of lesions during DNA synthesis.. Mol Cell. 36(4):620-30.
Mileti E, Matteoli G, Iliev ID, Rescigno M.  2009.  Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy.. PLoS One. 4(9):e7056.
Mileti E, Matteoli G, Iliev ID, Rescigno M.  2009.  Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy.. PLoS One. 4(9):e7056.
Noguchi E, Homma Y, Kang X, Netea MG, Ma X.  2009.  A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1.. Nat Immunol. 10(5):471-9.
Zhou Q, Mazloum N, Mao N, Kojic M, Holloman WK.  2009.  Dss1 regulates interaction of Brh2 with DNA.. Biochemistry. 48(50):11929-38.
Zhou Q, Mazloum N, Mao N, Kojic M, Holloman WK.  2009.  Dss1 regulates interaction of Brh2 with DNA.. Biochemistry. 48(50):11929-38.
Banerjee K, Andjelic S, Klasse PJohan, Kang Y, Sanders RW, Michael E, Durso RJ, Ketas TJ, Olson WC, Moore JP.  2009.  Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo.. Virology. 389(1-2):108-21.
Banerjee K, Andjelic S, Klasse PJohan, Kang Y, Sanders RW, Michael E, Durso RJ, Ketas TJ, Olson WC, Moore JP.  2009.  Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo.. Virology. 389(1-2):108-21.
Iliev ID, Spadoni I, Mileti E, Matteoli G, Sonzogni A, Sampietro GM, Foschi D, Caprioli F, Viale G, Rescigno M.  2009.  Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells.. Gut. 58(11):1481-9.
Iliev ID, Spadoni I, Mileti E, Matteoli G, Sonzogni A, Sampietro GM, Foschi D, Caprioli F, Viale G, Rescigno M.  2009.  Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells.. Gut. 58(11):1481-9.
Pugach P, Ray N, Klasse PJohan, Ketas TJ, Michael E, Doms RW, Lee B, Moore JP.  2009.  Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities.. Virology. 387(2):296-302.
Pugach P, Ray N, Klasse PJohan, Ketas TJ, Michael E, Doms RW, Lee B, Moore JP.  2009.  Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities.. Virology. 387(2):296-302.
Iliev ID, Mileti E, Matteoli G, Chieppa M, Rescigno M.  2009.  Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning.. Mucosal Immunol. 2(4):340-50.
Iliev ID, Mileti E, Matteoli G, Chieppa M, Rescigno M.  2009.  Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning.. Mucosal Immunol. 2(4):340-50.
Moore JP, Kuritzkes DR.  2009.  A pièce de resistance: how HIV-1 escapes small molecule CCR5 inhibitors.. Curr Opin HIV AIDS. 4(2):118-24.
Anastassopoulou CG, Ketas TJ, Klasse PJohan, Moore JP.  2009.  Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41.. Proc Natl Acad Sci U S A. 106(13):5318-23.